Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines.

[1]  D. Romero,et al.  Triple targeting of mutant EGFRL858R/T790M, COX-2, and 15-LOX: design and synthesis of novel quinazolinone tethered phenyl urea derivatives for anti-inflammatory and anticancer evaluation , 2023, Journal of enzyme inhibition and medicinal chemistry.

[2]  Zhen Wang,et al.  Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease. , 2022, Bioorganic chemistry.

[3]  K. Abouzid,et al.  Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study , 2021, Journal of enzyme inhibition and medicinal chemistry.

[4]  Zhen Wang,et al.  N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects. , 2021, Bioorganic chemistry.

[5]  M. Schmidt,et al.  Re-categorization of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) according to clinical relevance: Abandoning the ´traditional NSAID´ terminology. , 2021, The Canadian journal of cardiology.

[6]  D. Romero,et al.  Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. , 2021, European journal of medicinal chemistry.

[7]  A. Musa,et al.  Potential Anticancer Lipoxygenase Inhibitors from the Red Sea-Derived Brown Algae Sargassum cinereum: An In-Silico-Supported In-Vitro Study , 2021, Antibiotics.

[8]  Bei Wang,et al.  Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets , 2021, Signal Transduction and Targeted Therapy.

[9]  D. Romero,et al.  Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities , 2021, Journal of enzyme inhibition and medicinal chemistry.

[10]  A. El-Yazbi,et al.  The emerging role of COX-2, 15-LOX, and PPARγ in metabolic diseases and cancer: An introduction to novel multi-target directed ligands (MTDLs). , 2020, Current medicinal chemistry.

[11]  Ola I A Salem,et al.  Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. , 2020, Bioorganic & medicinal chemistry.

[12]  A. M. Said,et al.  Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors , 2020, Journal of enzyme inhibition and medicinal chemistry.

[13]  F. Dekker,et al.  A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1. , 2019, European journal of medicinal chemistry.

[14]  I. M. El-Ashmawy,et al.  Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies. , 2019, Bioorganic chemistry.

[15]  D. Wink,et al.  Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype , 2019, Redox biology.

[16]  Jans H. Alzate-Morales,et al.  Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies , 2018, Chemical biology & drug design.

[17]  Daling Zhu,et al.  15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma. , 2018, Prostaglandins & other lipid mediators.

[18]  C. Laprise,et al.  Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils , 2018, PloS one.

[19]  Tamer M. Ibrahim,et al.  Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents. , 2018, Bioorganic chemistry.

[20]  A. Ibrahim,et al.  Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy , 2018, Diabetologia.

[21]  Hamed I. Ali,et al.  Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities. , 2017, European journal of medicinal chemistry.

[22]  G. FitzGerald,et al.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice1,2[S] , 2017, Journal of Lipid Research.

[23]  Qiang Li,et al.  Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK/STAT1 and NOX2/p47phox Pathways , 2017, Oxidative medicine and cellular longevity.

[24]  Àngels González-Lafont,et al.  Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins , 2016, Proceedings of the National Academy of Sciences.

[25]  L. Abou-zeid,et al.  Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies. , 2016, European journal of medicinal chemistry.

[26]  A. Mansour,et al.  Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents , 2016, Scientific Reports.

[27]  H. Sadeghian,et al.  15-Lipoxygenase inhibitors: a patent review , 2016, Expert opinion on therapeutic patents.

[28]  H. Kuhn,et al.  Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). , 2015, Gene.

[29]  Constantinos G. Neochoritis,et al.  Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties. , 2015, Journal of medicinal chemistry.

[30]  Ling Zhao,et al.  Inflammatory responses and inflammation-associated diseases in organs , 2015, Oncotarget.

[31]  M. Newcomer,et al.  The Structure of Human 15-Lipoxygenase-2 with a Substrate Mimic* , 2014, The Journal of Biological Chemistry.

[32]  Daling Zhu,et al.  15-lipoxygenase-1/15-hydroxyeicosatetraenoic acid promotes hepatocellular cancer cells growth through protein kinase B and heat shock protein 90 complex activation. , 2013, The international journal of biochemistry & cell biology.

[33]  Hak-Ju Kim,et al.  Anti-inflammatory Effect of Oyster Shell Extract in LPS-stimulated Raw 264.7 Cells , 2013, Preventive nutrition and food science.

[34]  L. Soromou,et al.  Regulation of Inflammatory Cytokines in Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophage by 7-O-Methyl-naringenin , 2012, Molecules.

[35]  A. Zarghi,et al.  Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships , 2011, Iranian journal of pharmaceutical research : IJPR.

[36]  R. Nirogi,et al.  Convenient and Efficient Synthesis of Some Novel Fused Thieno Pyrimidines Using Gewald's Reaction , 2011 .

[37]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[38]  L. Eriksson,et al.  Photodegradation mechanism of nonsteroidal anti-inflammatory drugs containing thiophene moieties: suprofen and tiaprofenic acid. , 2009, The journal of physical chemistry. B.

[39]  T. Macdonald,et al.  2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: Implications for toxicity associated with zileuton , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[40]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[41]  Fatma E. M. El-Baih,et al.  Synthesis of some thienopyrimidine derivatives. , 2006, Molecules.

[42]  Garret A FitzGerald,et al.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.

[43]  Dairong Wang,et al.  Cardiovascular hazard and non-steroidal anti-inflammatory drugs. , 2005, Current opinion in pharmacology.

[44]  B. Cronstein.  Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility. , 2002, Cleveland Clinic journal of medicine.

[45]  D. Kniss,et al.  Blockade of nitric oxide formation down‐regulates cyclooxygenase‐2 and decreases PGE2 biosynthesis in macrophages , 1999, Journal of leukocyte biology.

[46]  F. Ragab,et al.  Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats. , 2017, Journal of photochemistry and photobiology. B, Biology.

[47]  G. Bartkowiak,et al.  Synthesis and Conformational Assignment of N-(E)-Stilbenyloxymethylenecarbonyl-Substituted Hydrazones of Acetone and o-(m- and p-) Chloro- (nitro-) benzaldehydes by Means of and NMR Spectroscopy , 2013 .

[48]  V. Poroikov,et al.  Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. , 2012, European journal of medicinal chemistry.

[49]  M. Ahmad,et al.  Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.

[50]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.